| Postum Eye Care Inc | |
|
13 Mechanic St, Bellingham, MA 02019-1679 | |
| (508) 657-1242 | |
| Not Available |
| Full Name | Postum Eye Care Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 13 Mechanic St, Bellingham, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225116189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4164 (Massachusetts) | Primary |
| Provider Name | Zainub Postum |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134204241 PECOS PAC ID: 3173593209 Enrollment ID: I20040727001478 |
News Archive
By injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second zap of a laser, a multi-institutional team of researchers from the Wake Forest University School of Medicine (WFUSOM), Wake Forest University Center for Nanotechnology and Molecular Materials, Rice University, and Virginia Polytechnic Institute and State University has developed a new type of therapy that effectively kills kidney tumors in nearly 80% of treated mice. Researchers say that the findings, which were published in the Proceedings of the National Academy of Sciences of the United States of America, suggest a potential future cancer treatment for humans.
Salvage radiation therapy to the prostatic fossa is often employed in patients with rising PSA after radical prostatectomy (RP). Interestingly, only 25% of men with rising PSA after RP have a positive prostatic fossa biopsy, yet 70% of men with a negative biopsy will have their PSA decline to undetectable levels following salvage external beam radiotherapy.
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice. The protein RGS2 can delay an egg's development into an embryo in order to allow time for sperm to arrive and merge with the egg in a healthy fertilization process. The embryo cannot survive without the male chromosomes.
BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2013.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Postum Eye Care Inc Po Box 1161, Bellingham, MA 02019-1679 Ph: (617) 642-4749 | Postum Eye Care Inc 13 Mechanic St, Bellingham, MA 02019-1679 Ph: (508) 657-1242 |
News Archive
By injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second zap of a laser, a multi-institutional team of researchers from the Wake Forest University School of Medicine (WFUSOM), Wake Forest University Center for Nanotechnology and Molecular Materials, Rice University, and Virginia Polytechnic Institute and State University has developed a new type of therapy that effectively kills kidney tumors in nearly 80% of treated mice. Researchers say that the findings, which were published in the Proceedings of the National Academy of Sciences of the United States of America, suggest a potential future cancer treatment for humans.
Salvage radiation therapy to the prostatic fossa is often employed in patients with rising PSA after radical prostatectomy (RP). Interestingly, only 25% of men with rising PSA after RP have a positive prostatic fossa biopsy, yet 70% of men with a negative biopsy will have their PSA decline to undetectable levels following salvage external beam radiotherapy.
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice. The protein RGS2 can delay an egg's development into an embryo in order to allow time for sperm to arrive and merge with the egg in a healthy fertilization process. The embryo cannot survive without the male chromosomes.
BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2013.
› Verified 7 days ago
Dr. Zainub Postum, OD Optometrist Medicare: Medicare Enrolled Practice Location: 13 Mechanic St, Bellingham, MA 02019 Phone: 617-642-4749 | |
Monica Miller, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 249 Hartford Ave Spc A170, Bellingham, MA 02019 Phone: 617-988-8136 | |
Maysa M Abbas, OD Optometrist Medicare: Medicare Enrolled Practice Location: 249 Hartford Ave, Bellingham, MA 02019 Phone: 774-295-2019 | |
Ashlynne Horton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 249 Hartford Ave Spc A170, Bellingham, MA 02019 Phone: 774-319-9933 |